Detalles de la búsqueda
1.
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Ann Surg Oncol
; 2022 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378634
2.
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
Ann Surg
; 273(4): 814-820, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31188198
3.
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
N Engl J Med
; 376(23): 2211-2222, 2017 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28591523
4.
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Ann Surg Oncol
; 27(Suppl 3): 979, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514803
5.
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Ann Surg Oncol
; 26(11): 3510-3516, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297674
6.
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Ann Surg Oncol
; 24(9): 2539-2546, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28447218
7.
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
Ann Surg Oncol
; 24(3): 669-675, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770345
8.
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
JAMA
; 318(10): 918-926, 2017 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28898379
9.
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Ann Surg
; 264(3): 413-20, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27513155
10.
Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
Ann Surg Oncol
; 23(10): 3317-23, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27384749
11.
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 23(5): 1522-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26714960
12.
Response to the article by Dietz et al. entitled "Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID19 pandemic. The COVID19 pandemic breast cancer consortium".
Breast Cancer Res Treat
; 182(2): 511-512, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32451680
13.
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.
Ann Surg Oncol
; 22(10): 3174-83, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26215198
14.
Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.
Ann Surg Oncol
; 21(13): 4104-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24756810
15.
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Ann Surg Oncol
; 21(10): 3261-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25099655
16.
Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
J Natl Cancer Inst
; 116(2): 334-337, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37756683
17.
Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
Ann Surg Oncol
; 20(4): 1275-81, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23054123
18.
Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
Ann Surg Oncol
; 20(10): 3279-85, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975302
19.
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.
Mol Ther
; 20(3): 679-86, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22186789
20.
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation.
Cancer
; 118(17): 4126-31, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22252278